Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
about
Biochemical effects of SIRT1 activatorsExperimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculatureGrape phytochemicals and associated health benefitsSirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in miceAntidepressant effects of resveratrol in an animal model of depressionChronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.Trans-Resveratrol Supplementation and Endothelial Function during the Fasting and Postprandial Phase: A Randomized Placebo-Controlled Trial in Overweight and Slightly Obese Participants.Red wine: A drink to your heart.Resveratrol attenuates azidothymidine-induced cardiotoxicity by decreasing mitochondrial reactive oxygen species generation in human cardiomyocytesChronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats.Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitorResveratrol: a medical drug for acute pancreatitis.Suppression of Nitric Oxide Production and Cardiovascular Risk Factors in Healthy Seniors and Hypercholesterolemic Subjects by a Combination of Polyphenols and Vitamins.Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen.Significance of wine and resveratrol in cardiovascular disease: French paradox revisitedPolyphenols in the treatment of inflammatory bowel disease and acute pancreatitisResveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway.The Sirtuin System: The Holy Grail of Resveratrol?Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1.Bioactivity and structure of biophenols as mediators of chronic diseases.Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease.Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.An overview of the efficacy of resveratrol in the management of ischemic heart disease.Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effectsEFFECT OF CHRONIC INGESTION OF WINE ON THE GLYCEMIC, LIPID AND BODY WEIGHT HOMEOSTASIS IN MICE.Endothelial Nrf2 activation: a new target for resveratrol?A toast to your health, one drink at a time.Resveratrol opposite effects on rat tissue lipoperoxidation: pro-oxidant during day-time and antioxidant at night.Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation.Two new anthraquinone malonylglucosides from Polygonum cuspidatum.Effect of resveratrol and pterostilbene on aging and longevity.A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia.Biological Activities of Stilbenoids.
P2860
Q24633830-C6C13C3B-540C-4FC8-AD56-65034456CF14Q27016095-BA0BBA09-0242-4055-8B55-37AD5D2F6E19Q28297955-FD3866AE-94B3-4879-BC46-77FBDD308BAFQ28539039-5E2C8F4D-2852-43E0-B9FA-FE8EC9373A00Q33663230-DF0220BE-DF51-4D23-A7AB-FFD678A38FB1Q33701938-84AF73C3-5B61-48EA-8846-8567BFCA2B04Q33818343-9BFD199D-EB80-4CD0-9C3D-6011CB69F8E9Q33852025-A2EDC1F9-B85A-420B-99E1-53997BBC166FQ34504802-FF5C5645-0934-4BE9-BF29-1366B033EB9EQ34787965-2A32CAFD-CC20-44C7-84D4-D6E005D1E2DBQ35314875-FF8548AC-33C1-40D3-87AB-87EE3DEC48B8Q36086859-9AECEB37-8F15-45CF-BA77-9C15F49A7113Q36147106-D07277E1-766F-4752-BEC5-42271B51F2A7Q36363692-B2138681-FF19-4B03-B257-FFB6A226F9EDQ36431841-6F9CA509-272F-4536-BAE8-73A1D1E2B349Q36511645-A5DB37AD-058C-400B-AC2D-E0659C1F6967Q36576621-3B9D83F3-D4AB-4FC2-AE5F-A5634986763BQ36613722-10B44CE9-4586-4E54-903B-FCA510998ADEQ36733062-0C0CD601-C2BA-4E3D-AE38-C3BCD6EA8B38Q37038768-9D02313C-136C-4287-83A0-8D15FE6B5019Q37307695-1F76AF52-B836-4635-A0DE-592DC3E6BA21Q37831940-B645D5A8-1145-4C85-B928-18C3D410A492Q37995917-F38DF621-C824-4145-976D-E3E0B0663888Q38557902-6E76A068-7D73-471A-B83C-3EBB3B2F4BF4Q38995157-43EFBC3E-9B50-4D4B-A51B-39BFC971313BQ40630534-F5CC12BF-4F33-4C14-B0ED-245E703D16EBQ41534121-49923469-F6F7-4B2C-8970-6D80C2AC7161Q42733136-F1CCC62C-8097-45D9-9E5A-D3E5B5DD4951Q42754353-AFA6E962-ADC2-484B-A8DD-285BAFB4B6E6Q43288954-F6D5BB9A-5667-4458-BA8C-D623842F3246Q45042358-EB1DF959-FA37-4F89-990A-8D3741277335Q46518447-F073946D-FB08-4B7D-86A5-3D6890144A54Q47279730-EB79FDB0-1C78-4975-9D19-42E3FC3FE4F7Q48139249-01A4A835-63DB-434B-A4AA-F901A11E2362Q55021760-08E20C1F-2940-4219-A342-3E5F2E16D9A1
P2860
Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Resveratrol provides late-phas ...... adenosine-mediated mechanism.
@ast
Resveratrol provides late-phas ...... adenosine-mediated mechanism.
@en
type
label
Resveratrol provides late-phas ...... adenosine-mediated mechanism.
@ast
Resveratrol provides late-phas ...... adenosine-mediated mechanism.
@en
prefLabel
Resveratrol provides late-phas ...... adenosine-mediated mechanism.
@ast
Resveratrol provides late-phas ...... adenosine-mediated mechanism.
@en
P2093
P1476
Resveratrol provides late-phas ...... adenosine-mediated mechanism.
@en
P2093
Alberto A E Bertelli
Franco Piccinini
Jan Willem De Jong
Livia Barenghi
Patricia Beemster
Robert De Jonge
Silvia Bradamante
P304
P356
10.1016/S0014-2999(03)01441-9
P407
P577
2003-03-01T00:00:00Z